Search

Your search keyword '"Minna, John"' showing total 116 results

Search Constraints

Start Over You searched for: Author "Minna, John" Remove constraint Author: "Minna, John" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
116 results on '"Minna, John"'

Search Results

1. A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer

2. Deep learning of cell spatial organizations identifies clinically relevant insights in tissue images

4. Author Correction: Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer

5. Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer

6. Establishment of reference standards for multifaceted mosaic variant analysis

9. Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer

10. Elevated NSD3 histone methylation activity drives squamous cell lung cancer

11. The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer

12. eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancer

13. EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer

14. Mechanical regulation of glycolysis via cytoskeleton architecture

16. Correction: LCE: an open web portal to explore gene expression and clinical associations in lung cancer

20. Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

21. Development and Validation of a Pathology Image Analysis-based Predictive Model for Lung Adenocarcinoma Prognosis - A Multi-cohort Study

22. Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

23. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

24. LCE: an open web portal to explore gene expression and clinical associations in lung cancer

28. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition

29. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

30. SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers

31. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

32. Erratum: NRF2 regulates serine biosynthesis in non–small cell lung cancer

33. NRF2 regulates serine biosynthesis in non–small cell lung cancer

34. Correction: Corrigendum: A pan-cancer proteomic perspective on The Cancer Genome Atlas

35. A small-cell lung cancer genome with complex signatures of tobacco exposure

36. A pan-cancer proteomic perspective on The Cancer Genome Atlas

38. Identification and Characterization of a Suite of Tumor Targeting Peptides for Non-Small Cell Lung Cancer

39. Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial–mesenchymal transition

41. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

42. Transient but Not Stable ZEB1 Knockdown Dramatically Inhibits Growth of Malignant Pleural Mesothelioma Cells

45. Identification of 5 novel genes methylated in breast and other epithelial cancers

47. A small-cell lung cancer genome with complex signatures of tobacco exposure

48. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

Catalog

Books, media, physical & digital resources